Atlas Trials

Everolimus With and Without Temozolomide in Adult Low Grade Glioma

Clinical trial NCT02023905 · TERMINATED

Trial details

NCT number
NCT02023905
Sponsor
University of California, San Francisco
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Low Grade GliomaWorld Health Organization (WHO) Grade II AstrocytomasOligodendrogliomasMixed Oligoastrocytomas
Start date
2014-03-19
Primary completion
2021-09-30
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.